Meetings, Congress News, Society News, Inside ESCRS, Patient Journey, Eye on Travel
New Tool Calculates Patient Travel Carbon Footprint


Stuart Hales
Published: Thursday, August 1, 2024
A new tool available on the ESCRS website will help ophthalmologists understand the carbon footprint associated with patient travel and encourage sustainable practices within the cataract and refractive surgeon community.
The Patient Travel Carbon Calculator assesses factors such as postoperative visits, travel distance, and transportation mode to help ophthalmologists understand the overall carbon footprint of their practice and make informed decisions. Additionally, the calculator lets doctors estimate the portion (typically about one-third) of the carbon footprint caused by cataract surgery, with the other main portion arising from surgical disposables.
Cataract surgery emits roughly 75 kilograms of carbon dioxide (CO2) per surgery, equivalent to the amount of CO2 absorbed by three trees per year. In Europe alone, cataract surgery is performed about 4.5 million times annually. As physicians, we can make a significant impact by reducing avoidable patient travel through changes in our practice patterns.
Using the Patient Travel Carbon Calculator in combination with the ESCRS SIDICS calculator will provide ophthalmologists with the tools needed to analyse their surgical practices and work towards a more sustainable climate.
Join us in prioritising sustainability and minimising our ecological footprint—calculate your impact today.

Tags: ESCRS Annual Congress, Barcelona, meeting, ESCRS, calculator, Patient Travel Carbon Footprint, Patient Travel Carbon Footprint Calculator, ESCRS SIDICS
Latest Articles
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.
Should Fuchs’ Dystrophy Patients Get Premium Lenses?
Patients’ demand for premium IOLs despite contraindications pose a challenge in Fuchs’ dystrophy treatment.
Avoiding Posterior Capsule Rupture
Imaging may help, but surgical technique is key for managing posterior polar cataracts.